Pharma Pulse 12/3/24: Early Access for Innovative Therapies, AI-Powered Drug Response Prediction Technology & more
The latest news for pharma industry insiders.
Passage to Asia: Early Access for Innovative Therapies
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
AI-powered drug response prediction technology is revolutionizing veterinary and human oncology by enabling personalized treatment plans through live cell testing, machine learning models, and data-driven precision medicine approaches.
Major Canadian News Outlets Sue OpenAI in New Copyright Case
A coalition of some of Canada’s biggest media companies is seeking billions of dollars in compensation for what they say is copyright infringement on their work through ChatGPT.
New Biovanta Study Shows Best Efficacy in Treating Common Cold
Common cold viruses contribute significantly to lost productivity and overall well-being, amounting to nearly $40 billion in annual productivity losses. Treatment with Biovanta could significantly lessen that impact, according to a paper published in the peer-reviewed journal PLOS ONE. The study presents findings from a large, multi-center, placebo-controlled clinical trial involving 157 participants with cold symptoms in six cities across the United States.
In clinical trials today, how can we better support research sites and empower patients throughout their trial journey?
Discover actionable insights and forward-thinking strategies in our latest Applied Clinical Trials Magazine article authored by Samantha Morley, Nishma Patel and Danielle Shadforth.
Read the article:https://hubs.la/Q02Z-Ljl0
#ClinicalTrials #PatientEmpowerment #SiteSupport #ClinicalSites #ClinicalResearch
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
